Navigation Links
Embolic Protection Devices (EPD) - Emerging Markets 2009-2015
Date:11/7/2013

DUBLIN, Ireland, November 7, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/qfnpf3/embolic) has announced the addition of the "Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" report to their offering.

BRICSS EP Devices market forecasts to reach at US$93.3 million by 2015 at a CAGR of 15.6% during the analysis period 2009-2015. China accounts for nearly 30% of the global value and India claims around 20% of the market. In terms of CAGR, India is the fastest growing regions while China, South Korea and Russia are just behind. Forecasts for balloon occlusion types indicate a close 47% of the market value while catheters occlusion devices account for nearly 40%. In case of procedures, coronary sector depicts the largest CAGR while peripheral artery and neurology segments come in second and third place respectively.

Publication Overview

The report Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in the EPD market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.

The report primarily focuses on:

- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand Of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies

The report covers the market analysis by product types and by procedures. The subdivisions are as:

- By Product
a. Balloon Occlusion Devices
b. Catheter Occlusion Devices
c. Filter Devices

- By Procedures
a. Carotid/Neurology
b. Coronary
c. Peripheral Artery

Companies Mentioned

- Abbott Vascular Devices
- Abiomed
- Advansource Biomaterials
- Aga Medical Corporation
- Atrium Medical Corp.
- Ats Medical
- Biophan Technologies
- Biosense Webster
- Boston Scientific Corp.
- Cardiac Science Corp.
- Cardiacassist
- Cardica
- Cardiomems
- Cook Group Incorporated
- Cordis Corporation
- Cryolife
- Idev Technologies
- Medtronic

... and many more.

For more information visit http://www.researchandmarkets.com/research/qfnpf3/embolic

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bayers Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
2. InspireMDs MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
3. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
4. Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
5. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
6. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
7. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
8. Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
9. TSI Respiratory Protection Roadshow Rated Top-Notch By Attendees
10. Sanarias Malaria Vaccine Yields Unprecedented Protection In Phase 1 Clinical Trial
11. iBio Obtains New IP Protection in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
(Date:2/11/2016)... 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial ... 2015. The Company also filed its Quarterly Report on Form ... the Securities and Exchange Commission today. --> ... --> --> Net sales for ... or 95%, to $5.4 million from $2.8 million for the ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... In the early or “honeymoon” stage ... to perfection, go out of their way to be romantic, and may exaggerate a ... look at any online dating profile. , A recent study from Queendom.com ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce and ... U.S. universities who will draw from Siemens’ deep knowledge of product development ...
(Date:2/12/2016)... ... February 12, 2016 , ... As a former television executive, owner Tal Rabinowitz ... no time to decompress, Rabinowitz found herself drawn to a casual meditation class while ... on her life, implementing a 20-minute-per-day meditation practice with her team. After her tenure ...
(Date:2/12/2016)... ... February 12, 2016 , ... Every winter, someone is killed, injured ... West Penn Burn Center, part of the Allegheny Health Network, has partnered ... you the “Space Heaters Need Space” campaign. , “Space Heaters Need Space” ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Erlanger Agency ... the greater Columbus, OH area. The latest campaign focuses on the fight against breast ... Donations are now being accepted here . , Carmen is a loving single ...
Breaking Medicine News(10 mins):